CD8A and neoplasm: These results confirm that by stimulating innate immune responses via induced tumor cell phagocytosis by APCs, the antitumor effect of combined TMZ and anti-CD47 treatment ultimately relies on the generation of adaptive immunity mediated by cytotoxic CD8+ T cells.